Cervical carcinoma
Therapeutic area
Oncology
Rare disease
No
- Definition
- A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Cervical carcinoma
- Therapeutic area
- Oncology
- cervical carcinoma
- Advanced Cervical Carcinoma
- Cancer of Cervix
- Cancer of the Cervix
- Cancer of the Cervix, Cancer of the Endometrium
- Cancer of the Uterine Cervix
- carcinoma of cervix
- carcinoma of cervix uteri
- carcinoma of the cervix
- carcinoma of the cervix uteri
- Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
- Carcinoma of the Cervix, Stage IVB
- carcinoma of the uterine cervix
- carcinoma of uterine cervix
- Cervical Carcinoma Stage II
- Cervical Carcinoma Stage IIB
- Cervical Carcinoma Stage III
- Cervical Carcinoma Stage IV
- Cervical Carcinoma, Non-SquamousType
- cervix carcinoma
- Cervix Carcinoma Recurrent
- cervix uteri carcinoma
- Locally Advanced Cervical Carcinoma
- Locally Advanced Unresectable Cervical Carcinoma
- Metastatic Carcinoma of the Cervix
And 11 more, listed on the interactive page.
- Severity
- Severe
- Oncology
- Reproductive Health
Sources for recorded values
- MONDO ID
- MONDO:0005131
- Parent condition
- MONDO:0002974
Related records
Broader conditions (23)
- Cancer
- Cancer or benign tumor
- Carcinoma
- Cervical cancer
- Cervix disorder
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Epithelial neoplasm
- Female reproductive organ cancer
- Female reproductive system disorder
- Female reproductive system neoplasm
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
- Reproductive system cancer
- Reproductive system disorder
- Reproductive system neoplasm
- Tumor of uterus
- Uterine cancer
Narrower conditions (35)
- Cervical adenocarcinoma
- Cervical adenoid basal carcinoma
- Cervical adenoid cystic carcinoma
- Cervical adenosquamous carcinoma
- Cervical adenosquamous carcinoma, glassy cell variant
- Cervical basaloid carcinoma
- Cervical clear cell adenocarcinoma
- Cervical endometrioid adenocarcinoma
- Cervical keratinizing squamous cell carcinoma
- Cervical large cell neuroendocrine carcinoma
- Cervical lymphoepithelioma-like carcinoma
- Cervical mucinous adenocarcinoma
- Cervical mucinous adenocarcinoma, minimal deviation variant
- Cervical non-keratinizing squamous cell carcinoma
- Cervical serous adenocarcinoma
- Cervical small cell carcinoma
- Cervical squamous cell carcinoma
- Cervical verrucous carcinoma
- Cervical villoglandular adenocarcinoma
- Early invasive cervical adenocarcinoma
Trials (86)
- A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
- A Community Based Intervention to Improve Cervical Cancer Screening Among Women in the Hispanic and East African Immigrant Community
- A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
- A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
- A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
- A Study of LY3435151 in Participants With Solid Tumors
- A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
- A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
- Adaptive Radiotherapy in Patients With Gynecological Tumors
- Barriers to Cervical Cancer Screening
- Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
- Can Text Reminders Improve Uptake of Cervical Screening?
- CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers
- Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
- Cervical Cancer Screening Intervention Among Korean American Women
- Cervical Cytology - Do SMS Reminders Increase Participation in the Cervical Screening Programme?
- Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy
- Clinical Study of Indocyanine Green Displaying Pelvic Nerve in Radical Operation of Cervical Cancer
- Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
Approved drugs (2)
- Bevacizumab
- Topotecan hydrochloride
Drugs in development (84)
- Abipapogene suvaplasmid Phase 2
- Aldesleukin Phase 1
- Amifostine Phase 1
- Antineoplaston A10 Phase 2
- Arsenic trioxide Phase 2
- Atezolizumab Phase 3
- Belotecan Phase 2
- Bemarituzumab Phase 1
- Bizalimogene ralaplasmid Phase 1
- Brivanib alaninate Phase 2
- Bryostatin 1 Phase 2
- Cabozantinib Phase 2
- Cadonilimab Phase 3
- Camrelizumab Phase 2
- Carboplatin Phase 3
- Catequentinib Phase 3
- Celecoxib Phase 1
- Cetuximab Phase 2
- Cisplatin Phase 3
- Cobolimab Phase 2
Other linked drugs (2)
- Alendronic acid
- Fluorouracil